Joe Biden beats President Donald Trump in three polls released last week. What was surprising is that Biden was able to pull off the feat despite the recent resurgence in Trump’s popularity as his administration confronts the coronavirus outbreak in the U.S.
Joe Biden posted a two-point lead over Donald Trump in an ABC News/Washington Post poll. Biden got 49 percent over Trump’s 47 percent based on results released on Sunday, according to Politico.
Biden also bested Trump in a Fox News survey among registered voters. Biden raked in 49 points against Trump’s 40 percent based on the results of Fox News’ survey, which was released last week.
Biden also led by 3 points in a polled conducted by Monmouth University. The results revealed that Biden got 48 percent against Trump’s 45 percent.
According to the publication, the results of the three polls show a consistent pattern. Donald Trump has improved his approval rating but it might not translate to a vote for his second term. “The polls suggest a slightly larger-than-usual slice of Democratic-leaning and independent voters are telling pollsters they now approve of the job Trump is doing as president — but support for giving him a second term lags behind among these same voters,” Politico wrote.
Trump’s approval rating reached a new high based on recent polls. The POTUS has an average approval rating of 47 percent, the highest since he became the President, NPR reported. The figure also represents a three-point increase over the last two weeks.
A Gallup poll revealed that 60 percent of American adults approve of how Trump is handling the coronavirus pandemic. Meanwhile, 51 percent of Fox News’ respondents approved of his handling of the health crisis. Meanwhile, both Reuters/Ipsos and Economist/YouGov polls revealed that 49 percent approved of his actions.
“No, I think that we've handled it really well,” Trump said on Monday. “The American public thinks that we've handled it well if you look at polling data.”
However, an expert said that the bounce to his popularity is minimal. “We're seeing although his numbers have inched up, it's still roughly in his zone of support,” Marist College Institute for Public Opinion director Lee Miringoff said. “Look, he's not getting the rally-around-the-president [effect] that presidents in crisis have gotten.”


FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



